Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
July 12, 2011
Patent Application Number
12623326
Date Filed
November 20, 2009
Patent Primary Examiner
Patent abstract
The present invention provides compounds that inhibit the activity of plasma kallikrein (PK) and methods of preventing and treating the formation of thrombin during or after a PK dependent disease or condition, for example, after fibrinolysis treatment.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
